8-KFiled Aug 5, 8:00 PM ET

Apyx Medical Corp Reports Q2 2026 Results

$APYX · Apyx Medical Corp

Research Summary

AI-generated summary of this SEC filing

Updated

Apyx Medical Corp Reports Q2 2026 Results

What Happened

  • On August 6, 2026, Apyx Medical Corporation announced and furnished a press release reporting its results of operations for the quarter ended June 30, 2026. The press release is attached to the Form 8-K as Exhibit 99.1.

Key Details

  • Filing date: August 6, 2026 (Form 8-K, Item 2.02).
  • Reporting period: Quarter ended June 30, 2026.
  • Press release attached as Exhibit 99.1 and incorporated by reference.
  • The filing also includes the Cover Page Interactive Data File (Inline XBRL) as Exhibit 104.

Why It Matters

  • The press release provides Apyx’s latest quarterly financial results and operational updates that investors use to assess revenue, profitability and short-term trends. Retail investors should read the attached release for specific numbers (revenue, net income or loss, cash flow, and any guidance or management commentary) because those details can influence investor decisions and stock performance.